Female Hair Loss: Causes, Treatments, and What Actually Works
%20Medium.jpeg)
Female hair loss is far more prevalent than most people realise. According to the Australasian College of Dermatologists, female pattern hair loss (the most common type) affects approximately 12 percent of women by the age of 29, rising to more than 25 percent by age 49 and over 50 percent by the age of 79. These numbers reflect what GPs and dermatologists see in clinical practice every day.
Prevalence also varies depending on the type of hair loss. While female pattern hair loss is the most common, other forms such as telogen effluvium (temporary shedding from stress or hormonal shifts) and alopecia areata (autoimmune-related) are also seen frequently. Healthdirect Australia notes that hair loss is one of the more common reasons women seek GP consultations, yet it remains significantly underdiagnosed because many women delay seeking help.
Part of the reason for that delay is the misconception that hair loss in women is purely cosmetic and therefore trivial. It is not. The psychological impact of hair loss in women has been well-documented in the medical literature, with studies linking it to decreased quality of life, heightened anxiety, and reduced self-esteem. Understanding that this is a common medical concern, not a vanity problem, is the first step towards getting the right support.
Hair loss in women does not follow a single pattern. There are several clinically recognised types, and identifying which one is involved is essential to finding the right approach to treatment. A GP can help determine the type through a clinical assessment and, where appropriate, blood tests or referral to a dermatologist.
Female Pattern Hair Loss (Androgenetic Alopecia)
Female pattern hair loss, also known as androgenetic alopecia, is the most common form of hair loss in women. Unlike the receding hairline typically seen in men, female pattern hair loss usually presents as a gradual widening of the part line and overall thinning across the top of the scalp, while the frontal hairline is generally preserved. The Ludwig classification system is commonly used by clinicians to describe the severity, ranging from mild thinning (Grade I) to extensive loss (Grade III).
The underlying mechanism involves a combination of genetic predisposition and hormonal influence, particularly the effect of androgens on susceptible hair follicles. However, many women with female pattern hair loss have normal androgen levels, which suggests that follicle sensitivity plays a significant role. This is an important distinction because it means that androgen levels on a blood test may appear normal even when hormonal hair loss is present.
Telogen Effluvium
Telogen effluvium is a temporary but often distressing form of diffuse hair shedding. It occurs when a large number of hair follicles are pushed prematurely into the resting (telogen) phase of the hair growth cycle. The shedding usually appears two to three months after the triggering event and can feel dramatic, with clumps of hair coming out in the shower or on a pillow.
Common triggers include childbirth, significant emotional stress, major illness, surgery, rapid weight loss, starting or stopping hormonal contraception, and nutritional deficiencies (particularly iron and zinc). In most cases, telogen effluvium resolves on its own once the underlying trigger is addressed, but recovery can take six to twelve months. Chronic telogen effluvium, lasting longer than six months, can also occur and may require more thorough clinical investigation.
Alopecia Areata
Alopecia areata is an autoimmune condition in which the body's immune system mistakenly attacks hair follicles, resulting in patchy, well-defined areas of hair loss. It can affect the scalp, eyebrows, eyelashes, or other areas of the body. According to DermNet, alopecia areata affects approximately two percent of the population and can occur at any age, though onset is most common before 30.
The condition is unpredictable. Some women experience a single episode with full regrowth, while others may have recurring episodes or more extensive involvement. Treatment is available and a GP can provide referral to a dermatologist for ongoing management.
Traction Alopecia
Traction alopecia results from chronic tension on the hair follicles, typically caused by tight hairstyles such as braids, ponytails, buns, or hair extensions. Over time, the repeated pulling can damage the follicle and lead to permanent hair loss in the affected areas, usually around the hairline and temples. The Australasian College of Dermatologists notes that early intervention is important, as the condition is reversible in its early stages but can become permanent if the traction continues.
Other Contributing Conditions
Several medical conditions can cause or contribute to hair loss in women, including thyroid disorders (both hypothyroidism and hyperthyroidism), polycystic ovary syndrome (PCOS), iron deficiency anaemia, and autoimmune conditions such as lupus. Certain medications, including some oral contraceptives, anticoagulants, antidepressants, and chemotherapy agents, can also affect hair growth. Identifying and treating any underlying condition is a critical part of managing hair loss effectively.
Understanding why hair loss happens is essential to knowing how to address it. In women, the causes are often interconnected, with several factors contributing at once. A thorough clinical assessment can help untangle which factors are most relevant.
Hormonal Changes
Hormones are one of the most significant drivers of hair loss in women. Fluctuations in oestrogen, progesterone, and androgen levels can all influence the hair growth cycle. Common hormonal triggers include:
- Menopause and perimenopause: The decline in oestrogen during the menopausal transition can unmask or accelerate androgen-driven hair thinning. Many women notice increased shedding during perimenopause, which can continue post-menopause.
- Pregnancy and postpartum: During pregnancy, elevated oestrogen levels often prolong the growth phase of hair, giving it a fuller appearance. After delivery, as hormone levels normalise, many women experience significant shedding (postpartum telogen effluvium), usually peaking around three to four months after birth.
- Polycystic ovary syndrome (PCOS): PCOS is associated with elevated androgen levels, which can contribute to hair thinning on the scalp while simultaneously causing unwanted hair growth elsewhere on the body.
- Thyroid dysfunction: Both an underactive and overactive thyroid can disrupt the hair growth cycle, leading to diffuse thinning.
Stress
Chronic stress and acute stressful events can trigger telogen effluvium by shifting a large proportion of hair follicles into the resting phase simultaneously. This is one of the most common causes of sudden, diffuse shedding in women. The hair loss itself can also create a cycle of anxiety, which may further prolong the condition.
Nutritional Deficiencies
Adequate nutrition is essential for healthy hair growth. Deficiencies that are commonly associated with hair loss include:
- Iron: Iron deficiency, even without frank anaemia, is one of the most frequently identified nutritional contributors to hair loss in women. The Royal Australian College of General Practitioners (RACGP) recommends checking ferritin levels as part of the initial investigation of hair loss.
- Zinc: Low zinc levels can impair the hair growth cycle and increase shedding.
- Vitamin D: Low vitamin D has been associated with hair loss, though the evidence for supplementation as a treatment is still emerging.
- Biotin: True biotin deficiency is rare but can cause hair loss when present. Routine biotin supplementation in the absence of a confirmed deficiency has limited evidence supporting its effectiveness for hair regrowth.
- Protein: Severe protein deficiency can cause hair loss, though this is uncommon in the Australian diet.
Medications and Medical Treatments
A range of medications can contribute to hair thinning as a side effect. Women experiencing hair loss should review their current medications with their GP, as adjusting or substituting a medication may help. It is important never to stop a prescribed medication without medical guidance.
Ageing
Age-related changes in hair are normal. Hair diameter tends to decrease after the age of 40, and the overall density of hair on the scalp gradually declines. This is a natural part of ageing and is distinct from pathological hair loss, though it can occur alongside conditions such as female pattern hair loss.
Treatment for female hair loss depends on the type, the underlying cause, and individual factors. What works for one person may not be appropriate for another, which is why a clinical assessment is an important first step. Here is an honest overview of the options with the strongest evidence.
Minoxidil (Topical)
Minoxidil is the most well-studied topical treatment for female pattern hair loss. In Australia, the two percent formulation is available over the counter from pharmacies (Schedule 3), while the five percent formulation is also available and sometimes used off-label in women under medical guidance.
Minoxidil works by prolonging the growth phase of the hair cycle and increasing blood flow to the follicles. A Cochrane systematic review found that topical minoxidil was significantly more effective than placebo in improving hair density in women with female pattern hair loss. Results typically require at least four to six months of consistent daily application before meaningful changes become visible. If treatment is stopped, any hair maintained by minoxidil will generally be lost within a few months.
Common side effects include scalp irritation and, less commonly, unwanted facial hair growth (particularly with higher concentrations). A GP can help determine whether minoxidil is appropriate based on the type and extent of hair loss.
Spironolactone (Oral, Prescription)
Spironolactone is an anti-androgen medication that is sometimes prescribed off-label for female pattern hair loss, particularly when there are signs of androgen excess. It works by blocking androgen receptors and reducing androgen production, which may help slow hormonally driven hair thinning.
Evidence for spironolactone in female hair loss is moderate, drawn primarily from observational studies and clinical experience rather than large randomised controlled trials. The Australasian College of Dermatologists includes spironolactone as a treatment option in its clinical guidance for female pattern hair loss. It is a prescription medication (Schedule 4) that requires regular monitoring, including blood pressure and potassium levels.
Spironolactone is not suitable for women who are pregnant or planning pregnancy due to the risk of feminisation of a male foetus. A thorough discussion with a GP or dermatologist is essential before starting this medication.
Iron and Nutritional Supplementation
When blood tests identify a deficiency, correcting it can make a meaningful difference to hair health. Iron supplementation in women with low ferritin levels may help reduce shedding, and the RACGP recommends targeting a ferritin level above 30 micrograms per litre for hair health, though some dermatologists suggest a higher threshold.
Zinc, vitamin D, and other micronutrient supplements may be recommended based on individual test results. However, supplementation in the absence of a confirmed deficiency is unlikely to produce significant hair benefits and can occasionally cause harm. Blood tests are a simple and important part of the assessment process.
Hormone Replacement Therapy (HRT)
For women experiencing hair thinning associated with menopause, hormone replacement therapy may help stabilise hair loss as part of its broader effects on oestrogen levels. However, HRT is not prescribed specifically for hair loss alone, and the decision to start HRT involves weighing a range of health considerations. Women considering HRT should discuss the full picture with their GP.
Platelet-Rich Plasma (PRP) Therapy
PRP therapy involves drawing a small amount of blood, processing it to concentrate the platelets, and injecting the platelet-rich plasma into the scalp. The theory is that growth factors in the platelets may stimulate hair follicle activity. Some clinical studies have shown promising results, but the evidence is still considered emerging, and PRP is not yet included in standard Australian clinical guidelines for hair loss. It is typically offered through dermatology or cosmetic clinics and is not covered by Medicare.
Low-Level Laser Therapy (LLLT)
Low-level laser therapy uses specific wavelengths of light to stimulate cellular activity in hair follicles. Some studies suggest a modest benefit in improving hair density, and devices are available for home use. The evidence is limited, and the Australian Therapeutic Goods Administration (TGA) regulates these devices. Results vary significantly between individuals.
What About Hair Growth Supplements?
The hair supplement market is substantial and growing, but the clinical evidence behind most products is limited. Supplements containing biotin, marine extracts, collagen peptides, and various herbal ingredients are widely marketed. For women without confirmed nutritional deficiencies, the benefit of these supplements is uncertain. A GP can help determine whether supplementation is warranted based on individual circumstances.
Managing expectations is one of the most important aspects of treating hair loss. There are no overnight solutions, and the timelines involved require patience and consistency.
For topical minoxidil, clinical trials suggest a minimum of four to six months of daily use before improvements in shedding or density become noticeable. Full results may take twelve months or longer. Photographs taken in consistent lighting can be a helpful way to track progress over time.
For spironolactone, clinical improvement may take six to twelve months. The medication tends to slow further loss first, with regrowth occurring gradually over a longer period.
Where hair loss is driven by a correctable cause such as iron deficiency or thyroid dysfunction, treating the underlying condition can lead to improvement, though hair regrowth is typically slow. The hair growth cycle means that it can take several months after the cause is resolved for new growth to become visible.
It is also important to understand what treatment can and cannot achieve. In female pattern hair loss, the goal of treatment is generally to slow further thinning and, where possible, achieve some degree of improvement. Complete restoration to a previous hair density is uncommon. A GP can help set realistic expectations based on the type and stage of hair loss.
Early intervention tends to produce better outcomes. Hair follicles that have been miniaturised for a long time are less likely to respond to treatment than those caught earlier in the process. This is one of the strongest arguments for seeking a clinical assessment sooner rather than later.
Worried about thinning hair?
Hair loss can feel like something to deal with alone, but it does not have to be. Abby Health is an online-first clinic with a care network of more than 300 clinicians, available 7 days a week, 365 days a year. Consultations are bulk billed for eligible patients with a valid Medicare card.
A GP consultation through Abby Health can include a clinical assessment of hair loss patterns, a review of medications and medical history, pathology requests for blood tests (including iron, ferritin, thyroid function, zinc, vitamin D, and hormonal panels), and where appropriate, prescriptions or referrals issued during the consultation itself.
Abby AI, our clinical decision-support tool, works behind the scenes to surface relevant patient history and health information so that your clinician starts each consultation informed and prepared. It supports the clinician, never replaces them.
With a 71 percent rebook rate, three in four patients choose to see the same doctor again, which means the kind of continuity that matters for ongoing management of conditions like hair loss. Whether the next step is a blood test, a prescription, or a referral to a specialist dermatologist, a conversation with a GP is the right place to begin.
Is it normal for women to lose hair every day?
Yes. It is normal to shed between 50 and 100 hairs per day as part of the natural hair growth cycle. Hair loss becomes a clinical concern when shedding exceeds this amount, when the hair noticeably thins, or when patches of loss develop. If the amount of hair in the shower drain, on the pillow, or in a brush seems to have increased significantly, it is worth discussing with a GP.
Can stress really cause hair loss?
Yes. Significant physical or emotional stress can trigger a condition called telogen effluvium, in which a large number of hair follicles enter the resting phase at the same time, leading to noticeable shedding two to three months later. The good news is that stress-related hair loss is usually temporary and resolves once the underlying stressor is addressed, though full recovery can take six to twelve months.
Will hair loss from iron deficiency grow back?
In many cases, hair loss associated with iron deficiency can improve once iron levels are adequately restored. However, regrowth takes time because of the natural length of the hair growth cycle. It may take three to six months after iron levels have normalised before new growth becomes visible. A GP can monitor progress through follow-up blood tests and clinical review.
Are hair growth supplements worth trying?
For women with a confirmed nutritional deficiency, targeted supplementation can support hair health. However, for women with normal nutrient levels, the evidence for over-the-counter hair growth supplements is limited. Many products are marketed with claims that go beyond their supporting evidence. A blood test is the best way to determine whether supplementation is likely to help.
Can a GP help with hair loss, or do I need to see a dermatologist?
A GP is an excellent starting point for investigating and managing hair loss. Most common types of female hair loss can be assessed and treated at the GP level, including ordering blood tests, prescribing medications, and providing ongoing monitoring. If the diagnosis is unclear, if the hair loss does not respond to initial treatment, or if a more specialised approach is needed, a GP can provide a referral to a dermatologist for further assessment.
Editorial Standards
Notice something that doesn’t look right? Let us know at support@abbyhealth.app
Authors
.avif)
